Recent Company News

• 04:44 AM ET Feb 06, 2026
  

  Xvivo Perfusion target price decreased to SEK245 from SEK408 at Stifel (SEK 197.60, -18.60)

• 04:26 AM ET Jan 27, 2026
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 10:06 AM ET Jan 27, 2026
  

  Transcript Intelligence: Xvivo Perfusion Q4 Earnings Guidance

• 10:05 AM ET Jan 27, 2026
  

  Transcript Intelligence: Xvivo Perfusion Q4 Earnings Q&A

• 10:05 AM ET Jan 27, 2026
  

  Transcript Intelligence: Xvivo Perfusion Q4 Earnings Themes

• 02:55 AM ET Jan 27, 2026
  

  StreetAccount Summary - European pre-market trading update

• 02:15 AM ET Jan 27, 2026
  

  Stifel transfers ALMDT.FP, BONEX.SS, XVIVO.SS

• 01:35 AM ET Jan 27, 2026
  

  Xvivo Perfusion reports Q4 adjusted EBIT SEK36.8M vs FactSet SEK25.6M [6 est, SEK20.4-29.6M] (SEK 218.80, 0.00)

• 04:05 PM ET Jan 20, 2026
  

  Bridge to Life (private) announces FDA De Novo clearance for VitaSmart HOPE System for liver transplantation (15:47ET)